Safety and Tolerability of CFTX-1554 in Healthy Subjects
Clinical trial NCT05260658 · COMPLETED
Trial details
- NCT number
- NCT05260658
- Sponsor
- Confo Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-09
- Primary completion
- 2023-02-10
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.